Related Experiment Video
Updated: May 23, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Treatment options for chronic myeloid leukemia
Maria Florencia Tanaka1, Hagop Kantarjian, Jorge Cortes
1Baylor College of Medicine, Hematology/Oncology Department, 1709 Dryden Rd, Room 574, Houston, TX 77030, USA.
Expert Opinion on Pharmacotherapy
|March 21, 2012
Summary
Second-generation tyrosine kinase inhibitors (TKIs) offer superior outcomes for chronic myeloid leukemia (CML) compared to imatinib. Patients with T315I mutations may benefit from stem cell transplantation.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Tyrosine kinase inhibitors (TKIs) are the primary treatment for chronic myeloid leukemia (CML).
- Several therapeutic aspects of CML treatment remain subjects of ongoing discussion and research.
Purpose of the Study:
- To provide a comprehensive review of CML management at diagnosis.
- To detail disease monitoring strategies and discuss special populations and case scenarios.
- To cover first-line (imatinib) and second-line (nilotinib, dasatinib) TKIs, including efficacy, side effects, and dosage.
Main Methods:
- Review of landmark studies on TKI efficacy and safety.
- Analysis of current treatment guidelines for CML.
- Overview of advanced-stage CML treatment, allogeneic stem cell transplantation, and investigational drugs.
Main Results:
- Second-generation TKIs demonstrate higher rates of optimal response than imatinib.
- Allogeneic stem cell transplantation is recommended for patients with the T315I mutation.
- Treatment for advanced-stage CML remains challenging.
Conclusions:
- Second-generation TKIs should be considered frontline therapy for CML due to superior response rates.
- Patients with the T315I mutation have a poorer prognosis and should be considered for stem cell transplantation.
- Further research is crucial for improving outcomes in advanced CML stages.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...